Amgen (AMGN) EPS (Basic) Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
169.38% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.52% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.83% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-185.57% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
4.66% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.77% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-7.69% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.26% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.66% |
| Dec 31, 2025 |
111.11% |
| Sep 30, 2025 |
13.47% |
| Jun 30, 2025 |
91.37% |
| Mar 31, 2025 |
1,633.33% |
| Dec 31, 2024 |
-18.75% |
| Sep 30, 2024 |
63.16% |
| Jun 30, 2024 |
-46.12% |
| Mar 31, 2024 |
-103.95% |
| Dec 31, 2023 |
-52.32% |
| Sep 30, 2023 |
-19.45% |
| Jun 30, 2023 |
4.88% |
| Mar 31, 2023 |
97.77% |
| Dec 31, 2022 |
-10.12% |
| Sep 30, 2022 |
20.78% |
| Jun 30, 2022 |
203.70% |
| Mar 31, 2022 |
-5.61% |
| Dec 31, 2021 |
20.86% |
| Sep 30, 2021 |
-3.77% |
| Jun 30, 2021 |
-73.62% |
| Mar 31, 2021 |
-7.77% |
| Dec 31, 2020 |
-3.14% |
| Sep 30, 2020 |
4.86% |
| Jun 30, 2020 |
-14.48% |
| Mar 31, 2020 |
-3.44% |
| Dec 31, 2019 |
-5.59% |
| Sep 30, 2019 |
14.24% |
| Jun 30, 2019 |
2.57% |
| Mar 31, 2019 |
-2.14% |
| Dec 31, 2018 |
151.61% |
| Sep 30, 2018 |
3.60% |
| Jun 30, 2018 |
19.45% |
| Mar 31, 2018 |
16.37% |
| Dec 31, 2017 |
-325.67% |
| Sep 30, 2017 |
2.96% |
| Jun 30, 2017 |
17.67% |
| Mar 31, 2017 |
11.51% |
| Dec 31, 2016 |
9.21% |
| Sep 30, 2016 |
9.76% |
| Jun 30, 2016 |
14.22% |
| Mar 31, 2016 |
18.31% |
| Dec 31, 2015 |
40.59% |
| Sep 30, 2015 |
50.92% |
| Jun 30, 2015 |
6.86% |
| Mar 31, 2015 |
50.00% |
| Dec 31, 2014 |
25.93% |
| Sep 30, 2014 |
-9.94% |
| Jun 30, 2014 |
22.16% |
| Mar 31, 2014 |
-25.65% |
| Dec 31, 2013 |
31.07% |
| Sep 30, 2013 |
25.69% |
| Jun 30, 2013 |
2.45% |
| Mar 31, 2013 |
27.33% |
| Dec 31, 2012 |
-5.50% |
| Sep 30, 2012 |
188.00% |
| Jun 30, 2012 |
29.37% |
| Mar 31, 2012 |
23.97% |
| Dec 31, 2011 |
0.00% |
| Sep 30, 2011 |
-61.24% |
| Jun 30, 2011 |
0.80% |
| Mar 31, 2011 |
1.68% |
| Dec 31, 2010 |
17.20% |
| Sep 30, 2010 |
-5.15% |
| Jun 30, 2010 |
0.00% |
| Mar 31, 2010 |
20.20% |
